| Source NDC Code |
|
Target HCPCS Code |
00310-3040-00
SAPHNELO 300 MG/2 ML VIAL
|
⇄
|
C9086
Inj, anifrolumab-fnia, 1 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2022 |
| Relationship End Date |
03/31/2022 |
| Number Of Items In Ndc Package |
2 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
00310-3040-00
SAPHNELO (PF) 150 MG/1 ML
|
⇄
|
J0491
INJECTION, ANIFROLUMAB-FNIA, 1 MG
|
| Detail Information |
| Relationship Start Date |
04/01/2022 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
2 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
00310-3040-00
SAPHNELO (PF) 150 MG/1 ML
|
⇄
|
J3490
UNCLASSIFIED DRUGS
|
| Detail Information |
| Relationship Start Date |
07/30/2021 |
| Relationship End Date |
03/31/2022 |
| Number Of Items In Ndc Package |
2 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
00310-3040-00
SAPHNELO 300 MG/2 ML VIAL
|
⇄
|
J3590
Unclassified Biologics
|
| Detail Information |
| Relationship Start Date |
01/01/2022 |
| Relationship End Date |
03/31/2022 |
| Number Of Items In Ndc Package |
2 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
00310-3040-00
Saphnelo
|
⇄
|
J0491
Inj anifrolumab-fnia 1mg
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|